Atoltivimab, maftivimab, and odesivimab-ebgn: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

29 April 2025

  • curprev 20:5420:54, 29 April 2025 Alara E. Dagsali talk contribs 13,818 bytes +13,818 Created page with "{{DrugProjectFormSinglePage |authorTag= Alara Ece Dagsali, M.D. |genericName=atoltivimab, maftivimab, and odesivimab-ebgn |aOrAn=a |drugClass=fixed-dose combination of three monoclonal antibodies |indicationType=treatment |indication=of infection caused by Orthoebolavirus zairense in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Orthoebolavirus zairense infection |adverseReactions=Hypersensitivity Reactions Inc..."
Retrieved from "https://www.wikidoc.org/index.php/Atoltivimab,_maftivimab,_and_odesivimab-ebgn"